CDX (ASX) Can CardieX match Omron?

Originally posted by cadence1: ↑

CardieX CEO Craig Cooper faces the race of his life if he wants to catch up to Ranndy Kellogg.

Kellogg is President and CEO of Illinois-based Omron Healthcare, part of the Omron Group, Kyoto, Japan.

On January 7, 2019 Ranndy Kellogg unveiled the world’s first wearable blood pressure monitor…and a strategic move into health coaching.

"There are 103 million hypertensive Americans", Kellogg said.

"This year, Omron Healthcare will offer a range of devices tailored to serve every one of them."

Kellogg added: "More than 80% of heart attacks and strokes are preventable with lifestyle changes.

"It all begins with regular blood pressure monitoring and achieving better insights into your heart health."

Wrist Watch
Branded HeartGuide, Omron’s breakthrough BP monitor comes in the form of a wrist watch. The watch band includes an inflatable cuff.

Omron says the cuff technology sets the device apart from other wearables that rely on sensors.

Omron filed more than 80 new patents to create HeartGuide which uses oscillometric tech and pumps and valves that are as small as a grain of rice.

HeartGuide has FDA clearance. It can process email, call and text notifications. It can track steps, aerobic steps, calories burned and distance.

And, with an accompanying HeartAdvisor app, it can monitor sleep quality and activity, including when the user gets into bed and when the user falls asleep.

Omron will soon launch a related Complete heart device including ECG/EKG/Electro Cardiogram tech developed by its AliveCor affiliate.

Based in Mountain View, CA, AliveCor is the first firm to receive FDA clearance for a medical-device accessory to the Apple Watch, a feat that Craig Cooper would no doubt envy...and wish to emulate.

Blumio
As reported, CardieX engineers are helping the group’s Silicon Valley-based Blumio affiliate to develop a BP wearable using a radar sensor linked to CardieX’s FDA-approved SphygmoCor central BP device.

The Blumio prototype is not designed as a wrist watch. It’s worn on the arm.

Craig Cooper promoted the Blumio tech on Twitter when attending the CES/Consumer Electronics Show 2019 in Las Vegas last month.

He joined Blumio CEO and co-founder Catherine Liao in a photoshoot. Interestingly, the wearables pair posed in a booth emblazoned with the logo of German semi-conductor and RFF/radar sensor goliath $IFX/Infineon.

Nearby, Omron Healthcare was busy showcasing its HeartGuide.

Sequels: Engadget gonged Omron with "Best of CES" award for best wearable. Tom's Guide awarded HeartGuide the "Best in Show" award for best health device at CES 2019. HeartGuide was also selected as a recipient of the Techlicious"Top Picks of CES" award, an award that acknowledges new product innovations.

Given that Omron Group has sold more than 200m BP units over 40 years, it’s not realistic to expect CardieX to match the group in the short term.

But as athletic Craig Cooper says, CardieX is not running a sprint. It’s running a marathon.

Health coaching
Cooper may be heartened that Omron is moving into health coaching. Why? Because the strategy aligns with - and endorses - the strategy being adopted by CardieX as it develops its InHealth Medical Services business.

Key to Omron’s health coaching initiative is its HeartAdvisor mobile app.

As mentioned, the app will allow users to input data that will show how diet, exercise, sleep quality and stress can impact BP readings.

HeartAdvisor will allow customized heart health coaching to act on this data. It will soon be available on Apple iTunes and Google Play stores.

Alexa
As well, Omron’s Connect app will allow users to ask Amazon’s Alexa to connect with and open their app, locate and read back their latest BP reading, calculate their average reading over a day/week/month and compare readings across different dates and times of day.

Alexa can also call out higher-than-normal readings and provide guidelines and tips to ensure accurate BP measurement.

While Omron has developed formidable heart technology, it doesn’t have the pioneering, gold standard SphygmoCor central BP testing tech developed by CardieX and used in all the top hospitals in the US.

This may give Craig Cooper a key edge in his marathon with Ranndy Kellogg.

Can CardieX match Omron? Unlikely. Can CardieX seek to emulate Omron? Absolutely.

Expand

'Can CardieX match Omron? Unlikely. Can CardieX seek to emulate Omron? Absolutely.'

Question is why would Cardiex want to emulate an inferior technology? Correct me if I'm wrong, but Omron's wearable wrist watch band measures the brachial blood pressure (peripheral blood pressure) which can be +/-30mm from a central aortic blood pressure reading .. so an individual relying on Omron's wearable could be seriously under or over normal range BP but not know it.

So someone wearing Omrons device gets a high or low BP the natural reaction is to become obsessed about it leading to elevated BP.
Theres irony here

Happy to be corrected.

Kellogg's spruik on FOX business Feb 2018 Chunky and dated tech but first mover advantage,,

No.	Vol.	Price($)
1	23000	13.5¢

No.

Vol.

Price($)

23000

13.5¢

Price($)	Vol.	No.
14.5¢	30600	2

Price($)

Vol.

No.

14.5¢

30600

No.	Vol.	Price($)
4	425123	0.038
3	346111	0.037
4	480000	0.036
8	1270000	0.035
1	100000	0.034

No.

Vol.

Price($)

425123

0.038

346111

0.037

480000

0.036

1270000

0.035

100000

0.034

Price($)	Vol.	No.
0.039	250000	1
0.040	328240	6
0.041	500000	1
0.042	182564	2
0.043	762158	2

Price($)

Vol.

No.

0.039

250000

0.040

328240

0.041

500000

0.042

182564

0.043

762158

(20min delay)
Last 13.5¢		Change -0.015(10.0%)		Mkt cap ! $17.65M

Open	High	Low	Value	Volume
15.5¢	17.5¢	13.5¢	$209.1K	1.362M

Can CardieX match Omron?, page-13

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Auric sniffs gold up to 12.1g/t through drilling at Spargoville prospects

Recce scores $6.75M R&D rebate

Cyclone signs MOU with Vale for development of Iron Bear play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Tyranna wraps up lithium drilling in Angola; says looking for other projects with different metals

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Buyers (Bids)

Sellers (Offers)

Can CardieX match Omron?, page-13

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Auric sniffs gold up to 12.1g/t through drilling at Spargoville prospects

Recce scores $6.75M R&D rebate

Cyclone signs MOU with Vale for development of Iron Bear play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Tyranna wraps up lithium drilling in Angola; says looking for other projects with different metals

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Buyers (Bids)

Sellers (Offers)